+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Influenza Drug"

Seasonal Influenza: Epidemiology Forecast in Asia-Pacific Markets to 2028 - Product Thumbnail Image

Seasonal Influenza: Epidemiology Forecast in Asia-Pacific Markets to 2028

  • Report
  • December 2019
  • 30 Pages
  • Asia Pacific
From
Seasonal Influenza: Epidemiology Forecast to 2028 - Product Thumbnail Image

Seasonal Influenza: Epidemiology Forecast to 2028

  • Report
  • October 2019
  • 45 Pages
  • Global
From
Seasonal Influenza: Competitive Landscape to 2026 - Product Thumbnail Image

Seasonal Influenza: Competitive Landscape to 2026

  • Report
  • November 2018
  • 49 Pages
  • Global
From
From
From
From
From
From
From
Influenzavirus B Infections - Pipeline Review, H2 2020 - Product Thumbnail Image

Influenzavirus B Infections - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 182 Pages
  • Global
From
Antiviral Therapeutics - Technologies, Markets & Companies - Product Thumbnail Image

Antiviral Therapeutics - Technologies, Markets & Companies

  • Report
  • November 2021
  • 620 Pages
  • Global
From
From
From
Loading Indicator

The Influenza Drug market is a subset of the larger Respiratory Drug market, which includes treatments for a variety of respiratory illnesses, such as asthma, COPD, and cystic fibrosis. Influenza drugs are used to treat the symptoms of the flu, such as fever, cough, and sore throat. These drugs can also help reduce the risk of complications from the flu, such as pneumonia. Commonly used influenza drugs include antivirals, such as oseltamivir and zanamivir, and anti-inflammatory drugs, such as ibuprofen and acetaminophen. Some companies in the Influenza Drug market include GlaxoSmithKline, Sanofi, Novartis, and AstraZeneca. Other companies include Roche, Merck, and Pfizer. Show Less Read more